How CordenPharma’s AmbioPharm deal strengthens U.S. and China peptide API supply
Find out how CordenPharma’s AmbioPharm deal expands peptide API capacity and reshapes global CDMO competition.
Pharma & Biotech
Pharma & Biotech
Why SV Health Investors’ EpiVax acquisition signals a bigger private equity push into immunogenicity services
SV Health Investors acquires EpiVax. Read why immunogenicity risk assessment is becoming a more strategic pharma services market.